GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
H

Hepion Pharmaceuticals HEPA · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.13

+7.13%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Latest on Hepion Pharmaceuticals

Our reporting

We have not reported on Hepion Pharmaceuticals yet.

Next results

3 Mar 2027

Due on 3 Mar 2027. Analysts expect earnings of -190.00 a share.

Past results

Reported against what analysts expected

13 Aug 202614 May 202612 Mar 202612 Nov 202515 Aug 20258 Apr 2025
Earnings per share-0.08-0.07-0.06-0.04-0.09-11.12
Forecast-200.00-200.00———-98.50

Key events

  1. 18 Mar 202550-to-1 reverse split
  2. 11 May 202320-to-1 reverse split
  3. 3 Jun 201970-to-1 reverse split
  4. 29 May 20188-to-1 reverse split
  5. 7 Feb 2014Listed

Hepion Pharmaceuticals in the news

Headlines from other publishers, linked to their own pages.

Sources and methodology

Data on this tab
Our reporting and our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.